Voclosporin

Unassigned

New Medicines

Voclera · Lupus nephritis - as an adjunct to use with mycophenolate

Information

Voclera
New molecular entity
Aurinia
Aurinia

Development and Regulatory status

Phase II Clinical Trials
Phase III Clinical Trials
Phase III Clinical Trials

Category

Calcineurin inhibitor
In 2001, prevalence of lupus nephritis was estimated at 4.4 per 100,000 UK population [1].
Lupus nephritis - as an adjunct to use with mycophenolate
Oral

Mild to moderate dry eye syndrome

Information

New formulation
Aurinia
Aurinia

Development and Regulatory status

None
None
Phase III clinical trials

Category

Aqueous, preservative free nanomicellar ophthalmic solution; topical calcineurin inhibitor type immunosuppressant
Dry eye syndrome is estimated to affect between 5% and 33% of the adult population worldwide . Dry eye syndrome is more common in people aged 50 years or older, in females and in those who have had refractive surgery [3].
Mild to moderate dry eye syndrome
Topical